Latest News

Debate: Should Dermatologists or Rheumatologists Manage Musculoskeletal Symptoms in Patients With Psoriasis?


 

FROM GRAPPA 2024

Collaborative Care

During the follow-up discussion, both Dr. Proft and Dr. Savage agreed that dermatologists and rheumatologists should be working together in managing patients. “What we need to do is steer our patients toward collaborative care with our rheumatologists by trying to minimize delays to treatment, by working together in parallel clinics, combined clinics, and on virtual [multidisciplinary teams],” said Dr. Savage.

Dr. Proft agreed. “We should join forces and make decisions together.”

Dr. Savage and Dr. Proft did not provide any financial disclosures.

A version of this article appeared on Medscape.com.

Pages

Recommended Reading

Experimental Topical Drug Shows Promise for Atopic Dermatitis and Plaque Psoriasis
MDedge Pediatrics
US Dermatologic Drug Approvals Rose Between 2012 and 2022
MDedge Pediatrics
A 4-month-old male was referred for a 3-week history of an itchy generalized rash that started on the neck
MDedge Pediatrics
A Look at the Evidence Linking Diet to Skin Conditions
MDedge Pediatrics
Use of Biologics for Psoriasis Found to Confer a Survival Benefit
MDedge Pediatrics
FDA Approves 10th Humira Biosimilar, With Interchangeability
MDedge Pediatrics
Combined Pediatric Derm-Rheum Clinics Supported by Survey Respondents
MDedge Pediatrics
Specialists Are ‘Underwater’ With Some Insurance-Preferred Biosimilars
MDedge Pediatrics
Recent Evidence for Home Phototherapy Benefits May Improve Access for Patients with Psoriasis
MDedge Pediatrics
Pyzchiva Receives FDA Approval as Third Ustekinumab Biosimilar
MDedge Pediatrics